Nitra Commits $20 Billion to Finance and Digitize Independent Medical Practices by 2028

New updates have been reported about Nitra.

Nitra has unveiled its Future of Care Initiative, a three-year, $20 billion commitment through 2028 to provide financing, technology, and operating infrastructure to independent medical practices across all 50 U.S. states. The AI-native healthcare platform aims to counter accelerating consolidation and cash-flow pressure on small and mid-sized physician groups by combining capital access with embedded software for core back-office functions.

Under the initiative, Nitra plans to deploy working capital loans, AI-driven claims factoring, equipment financing, revolving credit facilities, and growth capital to help practices launch, expand, and scale. The company, which reported more than 740% revenue growth in 2025 and over $1 billion in annualized processing volume, was already extending roughly $12 million in daily financing to independent practices as of 2026.

To support this expanded footprint, Nitra will grow its workforce from about 50 employees to more than 200 by the end of 2026, adding over 150 hires across sales, customer success, engineering, and operations. Management expects this build-out to enable support for more than 8,000 practices nationwide and to deepen adoption of its AI tools across scheduling, accounting, prior authorization, denial management, cash management, invoicing, and bill pay.

The initiative also emphasizes procurement and supply-chain savings, leveraging NitraMart’s catalog of over 50,000 medical and biopharma SKUs and relationships with major GPOs, distributors, and drug manufacturers to lower input costs for practices. Nitra currently serves thousands of physicians in more than 700 clinics, integrating payments, procurement, and patient administration into a unified operating system designed to reduce administrative overhead and improve financial visibility.

Strategically, the Future of Care Initiative positions Nitra as a capital and infrastructure partner to independent physicians seeking to preserve ownership in the face of payer pressure, regulatory complexity, and hospital or private-equity roll-ups. CEO Tim Hwang framed the move as an effort to let doctors maintain autonomy without sacrificing financial viability, signaling a long-term bet on independence as a durable segment of U.S. healthcare delivery.

To inform execution, Nitra is establishing a Future of Care Advisory Council composed of experienced physicians and healthcare operators who have built large independent practices. The council will be chaired by Dr. Richard Park, co-founder of Ascend Partners and founder and former CEO of CityMD, with additional members including leaders from ophthalmology and pain management who bring operational experience from scaled specialty practices.

Nitra’s strategic direction is further supported by a Board of Advisors with deep expertise in economics, fintech, and software-led operations, including former White House Council of Economic Advisers Chair Dr. R. Glenn Hubbard, Square co-founder Sam Wen, and former Intuit and Yahoo executive Raymond Stern. For executives evaluating the company, the scale of this financing pledge, the rapid revenue growth, and the targeted hiring plan collectively signal an aggressive expansion strategy aimed at making Nitra a central financial and operating node for independent U.S. medical practices.